Janux Therapeutics Inc (JANX)
56.71
-0.04
(-0.07%)
USD |
NASDAQ |
Dec 20, 16:00
56.81
+0.10
(+0.18%)
After-Hours: 20:00
Janux Therapeutics Total Liabilities (Quarterly): 38.92M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Rezolute Inc | 9.973M |
| Vir Biotechnology Inc | 257.63M |
| Cytokinetics Inc | 1.450B |
| Galectin Therapeutics Inc | 121.45M |
| Spero Therapeutics Inc | 69.65M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 695.02M |
| Shareholders Equity (Quarterly) | 656.10M |
| Current Ratio | 38.80 |